2-[4-(o-methoxyphenyl)piperazin-1-ylmethyl]-1,3-dioxoperhydroimidazo[1,5-a] pyridine as a new selective 5-HT1A receptor ligand

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 6, 1996, Pages 689-694

  López Rodríguez, María L ^a   Morcillo, Ma José ^b   Rosado, Ma Luisa ^a   Benhamú, Bellinda ^a   Sanz, Antonio M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; ALPHA 1 ADRENERGIC RECEPTOR; BUSPIRONE; DOPAMINE 2 RECEPTOR; IMIDAZO[1,5 A]PYRIDINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RAT;

EID: 0029923021     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00081-9     Document Type: Article

References (24)

1. (a) Zifa, E.; Fillion, G. Pharmacol. Rev. 1992, 44(3), 401.
2. (b) Humphrey, P. P. A. 5-Hydroxytryptamine receptors and drug discovery. Serotonin receptor subtypes: pharmacological significance and clinical implications; Langer, S. Z.; Brunello, N.; Racagni, G.; Mendlewicz, J., Eds.; Karger: Basel, 1992; Vol 1, pp. 129-139.
3. (c) Teitler, M. Med Chem. Res. 1993, 3, 273.
4. (d) Herndon, J. L.; Glennon, R. A. Serotonin receptors, agents and actions. Drug design for neuroscience, Kozikowski, A. P., Ed.; Raven Press, Ltd.: New York, 1993; pp. 167-212.
5. (e) Saudou, F.; Hen, R. Med. Chem. Res. 1994, 4, 16.
6. (a) Fletcher, A.; Cliffe, I. A.; Dourish, C. T. Trends Pharmacol. Sci. 1993, 14, 441.
7. (b) Hamon, M. Trends Pharmacol. Sci. 1994, 15, 36.
8. (c) Blier, P.; Montigny, C. Trends Pharmacol. Sci. 1994, 15, 220.
9. (a) Taylor, D. P.; Moon, S. L. Neuropeptides 1991, 19, 15.
10. (b) Levy, A. D., van de Kar, L. D. Life Sci. 1992, 51, 83.
11. (a) Raghupathi, R. K.; Rydelek-Fitzgerald, L.; Teitler, M.; Glennon, R. A. J. Med. Chem. 1991, 34, 2633.
12. (b) El-Bermawy, M.; Raghupathi, R.; Ingher, S. P.; Teitler, M.; Maayani, S.; Glennon, R. A. Med. Chem. Res. 1992, 2, 88.
13. (a) Abou-Gharbia, M.; Patel, U. R.; Webb, M. B.; Moyer, J. A.; Andree, T. H.; Muth, E. A. J. Med. Chem. 1988, 31, 1382.
14. (b) van Steen, B. J.; van Wijngaarden, I.; Tulp, M. Th. M.; Soudijn, W. J. Med. Chem. 1993, 36, 2751.
15. van Steen, B. J.; van Wijngaarden, I.; Tulp, M. Th. M.; Soudijn, W. J. Med. Chem. 1994, 37, 2761.
16. (a) Freed, M. E.; Day, A. R J. Org. Chem. 1960, 25, 2108.
17. (b) Winterfeld, K.; Schüler, H. Arch. Pharmaz. 1960, 293, 203.
18. 2O.
19. Clark, R. D.; Weinhardt, K. K.; Berger, J.; Fisher, L. E.; Brown, C. M.; MacKinnon, A. C.; Kilpatrick, A. T.; Spedding, M. J. Med. Chem. 1990, 33, 633.
20. Ambrosio, E.; Montera, M. T.; Fernández, I.; Azuara, C.; Orensanz, L. M. Neurosci. Lett. 1984, 49, 193.
21. Glennon, R. A.; Naiman, N. A.; Pierson, M. E.; Smith, J. D.; Ismaiel, A. M.; Titeler, M.; Lyon, R. A. J. Med. Chem. 1989, 32, 1921.
22. 2O: C, 50.80; H, 6.68; N, 12.47. Found: C, 50.49; H, 6.70; N, 12.12.
23. Köhler, C.; Hall, H.; Ögren, S. O.; Gawell, L. Biochem. Pharmacol. 1985, 34, 2251.
24. Titeler, M., Lyon, R. A., Davis, K. H., Glennon, R. A. Biochem. Pharmacol. 1987, 36, 3265.